CX3CR1 is dysregulated in blood and brain from schizophrenia patients

@article{Bergon2015CX3CR1ID,
  title={CX3CR1 is dysregulated in blood and brain from schizophrenia patients},
  author={Aur{\'e}lie Bergon and Raoul Belzeaux and Magali Comte and Florence Pelletier and Myl{\`e}ne Herv{\'e} and Erin J. Gardiner and N. Beveridge and Bing Liu and Vaughan Carr and Rodney J. Scott and Brian J Kelly and Murray J. Cairns and Nishantha Kumarasinghe and Ulrich Schall and Olivier Blin and Jos{\'e} Boucraut and Paul A. Tooney and E. Fakra and El Ch{\'e}rif Ibrahim},
  journal={Schizophrenia Research},
  year={2015},
  volume={168},
  pages={434-443}
}
The molecular mechanisms underlying schizophrenia remain largely unknown. Although schizophrenia is a mental disorder, there is increasing evidence to indicate that inflammatory processes driven by diverse environmental factors play a significant role in its development. With gene expression studies having been conducted across a variety of sample types, e.g., blood and postmortem brain, it is possible to investigate convergent signatures that may reveal interactions between the immune and… Expand
Transcriptome-wide mega-analyses reveal joint dysregulation of immunologic genes and transcription regulators in brain and blood in schizophrenia
TLDR
Two mega-analyses of a combined set of microarray data from postmortem prefrontal cortices and ex-vivo blood tissues provide an informative atlas for future pathophysiologic and biomarker studies of schizophrenia. Expand
Characterization of macrophages from schizophrenia patients
TLDR
Data suggest that overall the function of macrophages in SCZ is not impaired, and further studies with larger groups that enable the possibility to study clinical subgroups and perform additional screenings to asses the full phenotype of the mo-MΦs are needed to strengthen this conclusion. Expand
C4A mRNA expression in PBMCs predicts the presence and severity of delusions in schizophrenia and bipolar disorder with psychosis
TLDR
It is shown that C4A mRNA expression alone is positively associated with psychotic symptomatology, specifically the presence and severity of delusions, which is noteworthy given recent findings that demonstrate a critical role for complement proteins in synaptic pruning. Expand
Modeling a linkage between blood transcriptional expression and activity in brain regions to infer the phenotype of schizophrenia patients
TLDR
Variations in activity in the superior temporal gyrus were strongly linked to schizophrenia-associated gene expression and presence of disease, and analyses of larger data sets will shed further light on the relationship between peripheral molecular changes and disease-related behaviors and ultimately, aid the diagnosis of neuropsychiatric disease. Expand
Shedding light on the role of CX3CR1 in the pathogenesis of schizophrenia
TLDR
The general characteristics of the CX3CL1-CX3CR1 axis and the involvement of this signaling pathway in the physiological processes whose disruptions are reported to participate in mechanisms underlying schizophrenia are described. Expand
Brain-immune interactions in neuropsychiatric disorders: lessons from transcriptome studies for molecular targeting.
TLDR
The key transcriptomic techniques applied in investigating differentially expressed genes and pathways responsible for altered brain-immune interactions in neuropsychiatric disorders are discussed and the application of transcriptomics that can aid in identifying molecular targets in various neuroPsychiatric disorders is highlighted. Expand
A loss of mature microglial markers without immune activation in schizophrenia
TLDR
This results indicate a change in microglial phenotype rather than density, which was validated with the use of TMEM119/Iba1 immunostainings on temporal cortex of a separate cohort. Expand
Rewired Pathways and Disrupted Pathway Crosstalk in Schizophrenia Transcriptomes by Multiple Differential Coexpression Methods
TLDR
Three differential co-expression methods are applied to analyze five transcriptomic datasets derived from SCZ and matched normal postmortem brain samples to uncover biological pathways where internal correlation structure was rewired or inter-coordination was disrupted in SCZ to systematically identify rewired pathways, disrupted pathway crosstalk circuits, and critical genes and gene links in schizophrenia transcriptomes. Expand
Rare genetic variants in CX3CR1 and their contribution to the increased risk of schizophrenia and autism spectrum disorders
TLDR
The results strengthen the association between microglia-specific genes and neurodevelopmental disorders by detecting a statistically significant association between the variant Ala55Thr in CX3CR1 with SCZ and ASD phenotypes. Expand
Genetics of Schizophrenia: Historical Insights and Prevailing Evidence.
TLDR
This review seeks to synthesize perspectives from genetic and epigenetic literature on SZ through a qualitative review of risk factors and prevailing hypotheses and is left with a positive outlook for the future of elucidating the molecular genetic mechanisms underlying SZ and other complex neuropsychiatric disorders. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 134 REFERENCES
Inflammation-related genes up-regulated in schizophrenia brains
TLDR
The results indicate alterations of inflammation-related pathways in schizophrenia, and the observation in oligodendrocyte cells suggests that alterations in inflammatory-related genes may have consequences for myelination. Expand
Coding and Noncoding Gene Expression Biomarkers in Mood Disorders and Schizophrenia
TLDR
It is concluded that, while peripheral studies of expression are generating valuable results in pathways involving immune regulation and response, larger studies are required which hopefully will lead to robust biomarkers for treatment response and perhaps underlying variations relevant to these complex disorders. Expand
Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function
TLDR
Changes were observed in gene sets associated with synaptic vesicle recycling, transmitter release and cytoskeletal dynamics that suggest multiple, small but synergistic changes in gene expression that affect nerve terminal function. Expand
Genome-wide expression profiling of schizophrenia using a large combined cohort
TLDR
The most comprehensive analysis to date of expression patterns in the prefrontal cortex of schizophrenic, compared with unaffected controls is presented and provides evidence for a common underlying expression signature in this heterogeneous disorder. Expand
Regulation of immune-modulatory genes in left superior temporal cortex of schizophrenia patients: a genome-wide microarray study
TLDR
The present data support a brain-specific view of the role immune-modulatory genes may play in the left superior temporal cortex in schizophrenia, because immune functions in the patients are not disturbed. Expand
Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia
  • S. Glatt, I. Everall, +6 authors M. Tsuang
  • Biology, Medicine
  • Proceedings of the National Academy of Sciences of the United States of America
  • 2005
TLDR
A protocol is established for conservative analysis and interpretation of gene expression data from the dorsolateral prefrontal cortex of SZ patients using statistical and bioinformatic methods that limit false positives and the discovery of highly reliable and reproducible candidate risk genes and biomarkers for SZ. Expand
Transcriptomic evidence for immaturity of the prefrontal cortex in patients with schizophrenia
TLDR
Evidence is provided that pseudo-immaturity of the PFC resembling juvenile PFC may be an endophenotype of schizophrenia, and whether medications affect the juvenile-like gene expressions in the schizophrenic PFC is tested. Expand
Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia
TLDR
Changes in an inflammatory response pathway that are present in ∼40% of people diagnosed with schizophrenia are demonstrated, suggesting that therapies aimed at immune system attenuation in schizophrenia may be of direct benefit in the brain. Expand
RNA-Seq analysis implicates dysregulation of the immune system in schizophrenia
TLDR
Integration of gene expression and pathway analyses with genome-wide association may be an efficient approach to identify risk genes for schizophrenia. Expand
A Comparative Genomic Study in Schizophrenic and in Bipolar Disorder Patients, Based on Microarray Expression Profiling Meta-Analysis
TLDR
The aim of the study was to perform and interpret the results of a comparative genomic profiling study in schizophrenic patients as well as in healthy controls and in patients with bipolar disorder and try to relate and integrate the results with an aberrant amino acid transport through cell membranes. Expand
...
1
2
3
4
5
...